Study for the Treatment of Significant Steatosis With Xenical Followed by Treatment of Hepatitis C With Pegasys/Copegus

NCT00207311 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

FED

Sponsor class

Conditions

Fatty Liver
Hepatitis C

Interventions

DRUG: Xenical, Pegasys, Copegus
BEHAVIORAL: Xenicare Program

Sponsor

Brooke Army Medical Center

Collaborators

[object Object]
[object Object]